<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80437">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01685047</url>
  </required_header>
  <id_info>
    <org_study_id>CR-12-014-ID-HV</org_study_id>
    <nct_id>NCT01685047</nct_id>
  </id_info>
  <brief_title>A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias</brief_title>
  <acronym>inSighT</acronym>
  <official_title>A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <authority>Belgium: Ethics Committee</authority>
    <authority>Canada: Ethics Review Committee</authority>
    <authority>China: Ethics Committee</authority>
    <authority>Finland: Ethics Committee</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <authority>Germany: Ethics Commission</authority>
    <authority>Hong Kong: Ethics Committee</authority>
    <authority>India: Ethics Committee</authority>
    <authority>Italy: Ethics Committee</authority>
    <authority>Japan: Institutional Review Board</authority>
    <authority>Netherlands: Medical Ethics Review Committee (METC)</authority>
    <authority>United Kingdom: Department of Health</authority>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this investigation is to determine the prevalence of device-recorded ST
      segment changes occurring before appropriate ICD therapies (ATP or Shock) and to define
      their temporal relationship to ventricular arrhythmias.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">September 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Among patients with an appropriate ICD therapy (shock or ATP) for ventricular tachycardia or fibrillation, determine the proportion of patients who have characterized ST segment changes from baseline prior to the therapy.</measure>
    <time_frame>End of follow up period</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">470</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Merlin.net</arm_group_label>
    <description>Group 1 uses Merlin.net for remote monitoring, i.e. scheduled follow ups every 6 months in clinic, collection of ST Segment, ATP and Shock Therapy delivered alerts via Merlin.net.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non Merlin.net</arm_group_label>
    <description>Group 2 will not use Merlin.net, i.e. scheduled follow ups every 3 months in clinic for alert review during device interrogation.
The use of Merlin.net will be per physician's preference.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient is implanted with SJM ICD and has or is at high risk of CAD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient is implanted with an SJM ICD with ST Monitoring and ShockGuard™ features
             (and remote care feature in case Merlin.net will be used)

          -  The patient, in the opinion of the investigator, will not require ventricular pacing
             for more than 20% of the time.

          -  The patient, in the opinion of the investigator, has or is at high risk of CAD.

          -  The patient is ≥ 18 years of age.

          -  The patient is able to provide written Informed Consent prior to any investigational
             related procedure.

        Exclusion Criteria:

          -  The patient has longstanding persistent AF/AFl or permanent AF/AFl

          -  The patient has documented complete heart block.

          -  The patient is known to have uncontrolled ventricular bigeminy or trigeminy (PVCs on
             regular basis).

          -  The patient has severe Left Ventricular Hypertrophy resulting in interventricular
             conduction defect (IVCD).

          -  The patient has intermittent bundle branch blocks (BBB).

          -  The patient is unable to comply with the follow up schedule.

          -  The patient is participating in another investigational device or drug investigation.

          -  The patient is pregnant or is planning to become pregnant during the duration of the
             investigation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johannes SPERZEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kerckhoff Klinik, Bad Nauheim Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karolien Timmermans</last_name>
    <phone>+3227746741</phone>
    <email>ktimmermans@sjm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume Raux, PhD</last_name>
    <phone>+32 277 468 37</phone>
    <email>graux@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kerckhoff Klinik</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>D-61231</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Sperzel, MD</last_name>
      <phone>+49 6032 996 2239</phone>
      <email>j.sperzel@kerckhoff-klinik.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 30, 2014</lastchanged_date>
  <firstreceived_date>September 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Ventricular Arrhythmias</keyword>
  <keyword>ST Segment Changes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
